182 related articles for article (PubMed ID: 7448106)
1. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Bax ND; Tucker GT; Woods HF
Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
[TBL] [Abstract][Full Text] [Related]
2. Lidocaine kinetics predicted by indocyanine green clearance.
Zito RA; Reid PR
N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
[TBL] [Abstract][Full Text] [Related]
3. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
Bax ND; Tucker GT; Lennard MS; Woods HF
Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914
[TBL] [Abstract][Full Text] [Related]
4. Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.
Zito RA; Reid PR
J Clin Pharmacol; 1981; 21(2):100-5. PubMed ID: 7229115
[TBL] [Abstract][Full Text] [Related]
5. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.
Prescott LF; Adjepon-Yamoah KK; Talbot RG
Br Med J; 1976 Apr; 1(6015):939-41. PubMed ID: 1268491
[TBL] [Abstract][Full Text] [Related]
6. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of lignocaine.
Benowitz NL; Meister W
Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
Sawyer DR; Ludden TM; Crawford MH
Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
[TBL] [Abstract][Full Text] [Related]
9. Does indocyanine green predict lidocaine requirements?
N Engl J Med; 1978 Sep; 299(12):662-3. PubMed ID: 683244
[No Abstract] [Full Text] [Related]
10. Protein binding and disposition of lignocaine in the elderly.
Cusack B; O'Malley K; Lavan J; Noel J; Kelly JG
Eur J Clin Pharmacol; 1985; 29(3):323-9. PubMed ID: 4076329
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of disopyramide after intravenous infusion to patients with myocardial infarction and heart failure.
Bonde J; Angelo HR; Bødtker S; Svendsen TL; Kampmann JP
Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):278-82. PubMed ID: 4024955
[TBL] [Abstract][Full Text] [Related]
12. Lignocaine kinetics in cardiac patients and aged subjects.
Nation RL; Triggs EJ; Selig M
Br J Clin Pharmacol; 1977 Aug; 4(4):439-48. PubMed ID: 901735
[TBL] [Abstract][Full Text] [Related]
13. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
Upward JW; Holt D; Emery P; Akhras F; Jackson G
Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.
LeLorier J; Grenon D; Latour Y; Caillé G; Dumont G; Brosseau A; Solignac A
Ann Intern Med; 1977 Dec; 87(6):700-2. PubMed ID: 931206
[TBL] [Abstract][Full Text] [Related]
15. Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias.
Thomson AH; Kelman AW; de Vane PJ; Hillis WS; Whiting B
Ther Drug Monit; 1987 Sep; 9(3):283-91. PubMed ID: 3672571
[TBL] [Abstract][Full Text] [Related]
16. Influence of lignocaine on plasma protein binding and pharmacokinetics of verapamil in dogs.
Belpaire FM; De Rick A; Bourda A; De Smet F; Rosseel MT; Bogaert MG
J Pharm Pharmacol; 1990 Jan; 42(1):45-9. PubMed ID: 1969949
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
MacMahon B; Bakshi M; Branagan P; Kelly JG; Walsh MJ
Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
[TBL] [Abstract][Full Text] [Related]
18. Rapid prediction of individual dosage requirements for lignocaine.
Vozeh S; Berger M; Wenk M; Ritz R; Follath F
Clin Pharmacokinet; 1984; 9(4):354-63. PubMed ID: 6467768
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
[TBL] [Abstract][Full Text] [Related]
20. Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green.
Nix DE; DeVito JM; Whitbread MA; Schentag JJ
J Antimicrob Chemother; 1987 Feb; 19(2):263-9. PubMed ID: 3571046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
